Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  irofulven
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000069317, MGI-IROF-003, UARIZ-HSC-00305, NCT00033735

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-2005, JHOC-NABTT-2005, NCT00012038

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IROF-017, NCT00374660

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98009, MSKCC-98007, NCI-T97-0119, NCT00003390, T97-0119

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: DM97-308, P30CA016672, U01CA070172, MDA-DM-97308, NCI-T97-0113, CDR0000066469, T97-0113, NCT00003441

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: VU-VCC-THO-9817, NCI-T97-0106, T97-0106

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000066696, NCI-98-C-0162, MB-403, NCI-T98-0030, T98-0030, NCT00019552

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066761, U10CA031946, CLB-39805, CALGB-39805, NCT00003666

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066884, P30CA054174, UTHSC-9895011082, MGI-114.27.P98-03, SACI-IDD-98-18, NCI-V99-1517, NCT00003760

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-98221, NCI-T98-0071, T98-0071

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: CDR0000066939, UTHSC-IDD-98-23, SACI-IDD-98-23, NCI-T98-0060, T98-0060, NCT00003796

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067554, GOG-129L, NCT00005031

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: MSKCC-99072, NCI-T99-0096, NCT00005070, T99-0096

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 99-0468.cc, UCHSC-99468, NCI-T99-0070, T99-0070, NCT00005968

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 85
Sponsor: NCI
Protocol IDs: NCI-2012-02512, CDR0000269484, GOG-0146O, U10CA027469, NCT00053365

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: CTRG-G15/02, NCI-6041, 6041, NCT00062257

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IROF-019, NCT00124527

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IROF-018, NCT00124566

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01838, POG-9772, CDR0000066359, P9772, NCT00003370

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02309, MDA-ID-99060, NCI-T99-0043, CDR0000067207, T99-0043, NCT00003997
New Search